您所在的位置: 首页 --> 导师团队 --> 杨跃

导师基本信息

  • 姓名:杨跃
  • 性别:
  • 民族:蒙古族
  • 科室:胸外科二病区
  • 职称:主任医师 ,教授
  • 专业:肿瘤学 、肿瘤外科学
  • E-MAIL: zlyangyue@bjmu.edu.cn

学术论文 | 研究方向 | 科研项目 | 招生计划

Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties,J Exp Clin Cancer Res,,38(1): 481

Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer,Cancer Lett,Cancer Lett 2019; 442 53-67

Zhang Panpan#, Li shaolei#, Lv Chao, Si Jiahui, Xiong Ying, Ma Yuanyuan*, Yang Yue*,Theranostics,2018, 8(21):5890-5902.

Zhang P, Ma Y, Lv C, Huang M, Li M, Dong B, Liu X, An G, Zhang W, Zhang J, Zhang L, Zhang S, Yang Y. Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy. ,Cancer Sci. ,2016;107(11):1563-1571.

Ma Y, Li M, Si J, Xiong Y, Lu F, Zhang J, Zhang L, Zhang P, Yang Y. Blockade of Notch3 inhibits the stem-like property and is associated with ALDH1A1 and CD44 via autophagy in non-small lung cancer. ,Int J Oncol. 2016;48(6):2349-58 ,2016;48(6):2349-58

Wang Y, Wu N, Zheng Q, Wang J, Yan S, Li S, Liu Y, Chen J, Yang Y. Prediction of Surgical Outcome by Modeling Based on Risk Factors of Morbidity After Pulmonary Resection for Lung Cancer in Older Adults. ,Ann Thorac Surg. ,2016;102(3):971-8.

Wang Y, Wu N, Zheng Q, Wang J, Yan S, Li S, Liu Y, Chen J, Yang Y. Prediction of Surgical Outcome by Modeling Based on Risk Factors of Morbidity After Pulmonary Resection for Lung Cancer in Older Adults. ,Ann Thorac Surg. ,2016;102(3):971-8.

Lu F, Li S, Dong B, Zhang S, Lv C, Yang Y. Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients. ,Thorac Cancer. ,2016;7(1):17-23.

Ma Y, Zhang P, An G, Zhang X, Zhang L, Si J, Zhang J, Yang Y. Induction of Patient-Derived Xenograft Formation and Clinical Significance of Programmed Cell Death Ligand 1 (PD-L1) in Lung Cancer Patients. Med Sci Monit. ,Med Sci Monit. ,2016;22:4017-4025.

Chao Lv; Chao An; Qin Feng; Yuanyuan Ma; Shaolei Li; Jia Wang; Jianzhi Zhang; Xing Wang; Shi Yan; Jian Fang; Yinxiang Wang; Fenlai Tan; Yue Yang. A Retrospective Study of Stage I-IIIa Lung Adenocarcinoma after Resection: What is the Optimal Adjuvant Modality for Patients with EGFR Mutation?, Accepted by ,Clinical Lung Cancer ,2015 Nov;16(6):e173-81.

Feng Yuan, Zheng Qingfeng,. Wang Jia, Lv Chao,Yan Shi,Wang Yuzhao,An Chao, Yang Yue. Influence of metastatic status and number of removed lymph nodes on survival of patients with squamous esophageal carcinoma ,Medicine ,2015 Dec;94(48):e1973.

CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer. ,World J Surg Oncol. ,2017;15(1):34

Impact of maximum standardized uptake value of non-small cell lung cancer on detecting lymph node involvement in potential stereotactic body radiotherapy candidates. ,J Thorac Dis ,2017;9(4):1023-1031

Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non-small cell lung cancer. ,Thorac Cancer. ,2017;8(2):97-105

2015年度“扬帆”计划重点医学专业--肺癌 , 课题负责人 , 2015.1.1~2017.12.31, 北京市医管局 ZYLX201509

随机、开放、多中心评估埃克替尼用于EGFR突变阳性的II-IIIA期肺腺癌术后辅助治疗的前瞻、探索性临床研究 , 课题负责人 , 2014.12.1~2017.11.30, 浙江贝达药业有限公司

早期肺癌的手术范围 , 子课题负责人 , 2015.6.1~2017.9.15, 北京市科委课题/D141100000214002

研究生招生计划
招生年度 招生专业 学位级别 学位类型 研究方向 选拔方式
2021 肿瘤学 博士 科学学位 胸部肿瘤的转化及基础研究 申请考核制

学习、工作经历

  • 2000.4.1~2004.8.1,在美国University of Rochester病理系肿瘤细胞分子生物学实验室从事博士后工作